Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma.
World J Gastrointest Oncol
; 16(6): 2380-2393, 2024 Jun 15.
Article
in En
| MEDLINE
| ID: mdl-38994149
ABSTRACT
Hepatic artery infusion chemotherapy (HAIC) has good clinical efficacy in the treatment of advanced hepatocellular carcinoma (HCC); however, its efficacy varies. This review summarized the ability of various markers to predict the efficacy of HAIC and provided a reference for clinical applications. As of October 25, 2023, 51 articles have been retrieved based on keyword predictions and HAIC. Sixteen eligible articles were selected for inclusion in this study. Comprehensive literature analysis found that methods used to predict the efficacy of HAIC include serological testing, gene testing, and imaging testing. The above indicators and their combined forms showed excellent predictive effects in retrospective studies. This review summarized the strategies currently used to predict the efficacy of HAIC in middle and advanced HCC, analyzed each marker's ability to predict HAIC efficacy, and provided a reference for the clinical application of the prediction system.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
World J Gastrointest Oncol
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
China